Stock·NYSE·Utilities
PG&E Corporation (PCG)
- Market cap
- $39.30B
- P/E
- 9.49
- Dividend yield
- 1.53%
- Street target
- $18.50median of 17 analysts
- 52-week range
- $11.77 $19.16
The short version
Where PCG stands today, in four lines, and what CleaRank Financial AI makes of it.
PCG at a glance
PG&E Corporation (PCG): Hold, 48/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($14.55 and $16.38).
- Earnings PCG beat estimates in 4 of its last 7 quarters, yet fell the next day after 1 of those beats.
- Insiders Insiders sold $9.0M and bought $211K over the last 18 months.
- Valuation P/E of 9.5 against 22.8 for the Utilities sector: a discount to peers (-58%).
Figures as of October 17, 2026.
CleaRank Financial AI
CleaRank rates PG&E Corporation (PCG) Hold, with a model score of 48/100.
Valuation lifts the score most: the P/E of 9.49 is 58.4% below the sector median (a discount to peers) and the P/S of 1.52 is 53.9% below the sector median. The trend holds it back most: the price is 20.11% below its 200-day average and 10.04% below its 50-day average, and the 50-day average is 11.19% below the 200-day. The 50-day average stands at $14.55 and the 200-day at $16.38. Over the past year the price fell 20.67%.
Only on CleaRank
Figures we compute ourselves from PCG's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $13.09 is 10.0% below the 50-day simple moving average of $14.55.Price above its 200-day average ›
The price is 20.1% below the 200-day simple moving average of $16.38.50-day average above the 200-day ›
The 50-day average ($14.55) is 11.2% below the 200-day average ($16.38), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 18% of its 52-week range, between $11.77 and $19.16.
PCG share price
Pick a period: each tab shows how far PCG has moved over it, to the last close.
Today's trading
Where PCG sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
5/5P/E below the sector median ›
The trailing P/E of 9.49 is 58.4% below the Utilities median of 22.8.P/S below the sector median ›
The price-to-sales ratio of 1.52 is 53.9% below the sector median of 3.3.Profitable over the last 12 months ›
Net income over the last 12 months was $3.1B on revenue of $25.8B, a net margin of 11.8%.Beat estimates in most recent reports ›
PCG beat the EPS estimate in 4 of its last 7 reports.Pays a dividend ›
The trailing dividend yield is 1.53%, or $0.2 a share a year.
Key statistics
The headline figures for PCG.
As of October 17, 2026, PCG trades at $13.09, with a market value of $39.30B, a P/E ratio of 9.49 and a dividend yield of 1.53%.
What the numbers say
CleaRank Financial AI's reading of PCG's valuation, growth and risks.
PG&E Corporation (PCG) screens as a discount to peers. Its P/E of 9.49 is 58.4% below the 22.8 median P/E of Utilities stocks. Measured against sales, the price-to-sales ratio of 1.52 is 53.9% below the sector median of 3.3. The company has a market capitalisation of $39.3B and trailing earnings of $1.38 per share.
PCG's growth lags the sector: revenue rose 0.10% in the latest year, while the sector median is 4.1%. The company keeps a net margin of 11.83% and an operating margin of 24.79%. Its return on equity of 9.32% sits below the sector median of 9.6%. On the balance sheet, debt-to-equity is 1.89, and the trailing dividend yield is 1.53%, or $0.2 per share annually.
PCG's most recent report, on July 23, 2026, beat the estimate by 11.11%, with $0.4 a share against a $0.36 estimate. The market agreed: the stock rose 1.77% the following session.
PCG has beaten the EPS estimate in 4 of its last 7 reports. Those beats have not reliably lifted the shares, which fell the following session after 1 of the 4 beats. For this fiscal year, analysts average an EPS estimate of $1.65, a change of 9.8%. For next year they expect $1.80, a change of 9.3%.
Normal swings for PCG run at about 1.96% a day. Until the price regains its moving averages, the trend works against holders. The price is 31.68% below its 52-week high of $19.16. Insiders sold $9.0M over the last 18 months and bought $211K, though sales of this kind are often planned in advance and say less than purchases would.
PCG against the Utilities sector
How PCG compares with the median Utilities stock CleaRank tracks.
Price to earnings vs sector: PCG trades at a notable discount to sector peers (-58%), which may indicate undervaluation or specific company headwinds.
Return vs XLU: Since May 6, 2025, PCG has lost 23.2% against a gain of 4.8% for XLU.
Performance against XLU
PCG and the Utilities sector fund over the same days.
Revenue and earnings
How much PCG sells, and how much of it becomes profit.
Revenue growth: Revenue grew 2.1% in FY2025 to $24.9B, from $24.4B a year earlier.
Profit margin: The net margin was 10.8% in FY2025, up from 10.3% the year before.
Profitable: PCG earned $2.7B in FY2025.
Earnings reality check
Did PCG beat what analysts expected, and how did the stock react?
Earnings record: PCG beat the analyst estimate in 4 of the last 7 quarters.
Market reaction: The stock fell in the first session after 1 of those 4 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 23, 2026after close | $0.36 | $0.40 | +11.11% | +1.77% | +1.37% |
| Apr 23, 2026after close | $0.40 | $0.43 | +7.50% | -1.31% | -1.25% |
| Oct 23, 2025after close | $0.43 | $0.50 | +16.28% | +0.61% | -2.45% |
| Jul 31, 2025after close | $0.32 | $0.31 | -3.13% | +0.71% | +7.35% |
| Apr 24, 2025after close | $0.34 | $0.33 | -2.94% | -1.44% | -4.14% |
| Feb 13, 2025after close | $0.31 | $0.31 | +0.00% | -3.53% | +0.88% |
| Nov 7, 2024after close | $0.32 | $0.37 | +15.63% | +1.18% | +3.09% |
As of October 17, 2026, PCG has beaten the analyst EPS estimate in 4 of its last 7 reported quarters and fell in the first trading session after 1 of those beats; its latest report, on July 23, 2026, came in 11.11% above the estimate and the stock moved +1.77% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 46.8, in neutral territory.RSI above 50 ›
An RSI of 46.8 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of PCG
The score, the reasoning behind it, and what could move the price next.
PCG is trading in a downtrend. The stock sits at $13.09, which is 10.04% below its 50-day average of $14.55 and 20.11% below its 200-day average of $16.38. Near the bottom of its 52-week range, the price is 11.21% above the low of $11.77 and 31.68% below the high of $19.16. Both averages point the same way, with the 50-day sitting 11.19% below the 200-day.
The record is negative across every period shown: the price fell 24.42% over the past three months, fell 24.16% over the past six months and fell 20.67% over the past year. Volume in the last session ran 32.6% below its average, on a day the price rose 1.00%. The 14-day RSI of 46.8 is in the neutral zone, and the MACD line is negative.
Earnings beat ›
The July 23, 2026 report beat the EPS estimate by 11.11%, and the share price rose 1.77% in the first session after it.
Source: Earnings report, July 23, 2026Rating reaffirmed ›
Barclays kept its Overweight rating on October 12, 2026.
Source: Analyst action, Barclays, October 12, 2026
Analyst downgrade ›
UBS downgraded it to Neutral from Buy on September 23, 2026.
Source: Analyst action, UBS, September 23, 2026
- The two nearest levels to watch are the 50-day SMA at $14.55, which sits above the price, and the 20-day EMA at $13.05, which sits below it.
- The 14-day RSI reads 46.8, in the neutral zone, with the MACD line negative; readings above 70 or below 30 mark stretched momentum.
- The share price climbed 1.77% in the first session after the July 23, 2026 report. Over the last 7 reports, PCG has beaten estimates in 4.
PCG is priced under both its 50-day ($14.55) and 200-day ($16.38) averages, and that is why the trend reads down. A move back above the 50-day would be the first sign of repair. The closest level above the price is the 50-day SMA at $14.55.
The next level below the price is the 20-day EMA, at $13.05. The 14-day RSI reads 46.8, which places PCG in neutral territory between 40 and 60.
Technical indicators
Momentum and trend for PCG, from its daily closes.
As of October 17, 2026, with PCG at $13.09, its 14-day RSI is 46.8 (neutral territory), its 50-day simple moving average is $14.55 and its 200-day is $16.38.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What PCG moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, PCG's 1-year correlation of daily returns is +0.21 with S&P 500 (SPY), +0.12 with Nasdaq 100 (QQQ), -0.01 with Bitcoin (BTC) and +0.06 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
1/3Most analysts rate it a buy ›
8 of 17 analysts rate it a buy or strong buy, 9 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $18.50 is 41.3% above the price.More buy ratings than three months ago ›
8 of 17 rate it a buy now, against 14 of 17 three months ago.
PCG Wall Street View
12-month price targets
The price, $13.09, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 12, 2026 | Barclays | Maintains | Overweight |
| Oct 12, 2026 | JP Morgan | Maintains | Overweight |
| Sep 23, 2026 | UBS | Downgrade | Neutral |
| Sep 18, 2026 | Morgan Stanley | Maintains | Equal-Weight |
| Sep 4, 2026 | B of A Securities | Maintains | Neutral |
| Sep 3, 2026 | Barclays | Maintains | Overweight |
As of October 17, 2026, 17 Wall Street analysts cover PCG: 8 rate it a buy or strong buy, 9 a hold and 0 a sell or strong sell. Their 12-month price targets range from $14.00 to $24.00, with a median of $18.50, 41.3% above the price of $13.09.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
PCG trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from PCG's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much PCG tends to move, against the market and on its own.
The long record
PCG's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
1/4Average daily move under 2% ›
The price has moved 1.96% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 91.4%, from September 2017 to November 2019; the price is still 80.9% below that peak.Most 1-year holds ended higher ›
46% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $2,283.43, against $42,055 in the S&P 500 (SPY).
PCG Drawdowns & Recovery
As of October 17, 2026, PCG's worst peak-to-trough fall over the last 10 years with dividends reinvested was -91.4% (September 2017 to November 2019); it is still 80.9% below that peak, and 46% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into PCG in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: PCG trailed the S&P 500 over this period: $2,283.43 against $42,055.
A $10,000 investment in PCG in October 2016 would be worth about $2,283 today with dividends reinvested, compared with about $42,055 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to PCG, and which have not.
Strongest month, February: an average of +6.44%, up in 5 of 10 years.
Weakest month, January: an average of -4.02%, up in 3 of 10 years.
This month, October: has averaged -1.01%, up in 6 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, PCG's strongest calendar month has been February (average +6.44%, up in 5 of 10 years) and its weakest January (average -4.02%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in PCG, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in PCG today could grow to about $5,986 by 2036 in the base case, with a 90th-percentile outcome near $45,413 and a 10th-percentile outcome around $789. The simulation models price only; at today's 1.53% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
PCG Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $10.66 for PCG by 2030 in the base case, from $13.09 today (0.8x over 4 years). The 10th-percentile path ends near $2.96. These are outcomes of a Monte Carlo simulation run on PCG's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $6.55 | $12.44 | $23.60 | |
| 2028 | $4.77 | $11.81 | $29.24 | |
| 2029 | $3.70 | $11.22 | $34.05 | |
| 2030 | $2.96 | $10.66 | $38.40 | |
| 2031 | $2.42 | $10.13 | $42.44 |
Method: a lognormal simulation of PCG's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
PCG insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $211K on the open market and sold $9.0M.
As of October 17, 2026, PCG insiders reported 15 open-market sales worth $9.0M and 2 open-market purchases worth $211K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 30, 2026 | John O Larsen
Director
|
Buy | 7.5K | $91.5K |
| Sep 4, 2026 | William Craig Fugate
Director
|
Sell | 6.5K | $89.4K |
| Jul 31, 2026 | Alejandro T Vallejo
Officer
|
Grant | 11.2K | - |
| Jul 22, 2026 | Marlene Santos
Divisional Officer
|
Sell | 158.3K | $2.8M |
| Jul 22, 2026 | Kerry Whorton Cooper
Director
|
Sell | 1.3K | $22.5K |
| Jun 15, 2026 | Carla J Peterman
President
|
Sell | 31.8K | $530.2K |
| Jun 5, 2026 | Mark E. Ferguson III
Director
|
Grant | 10.7K | - |
| Jun 2, 2026 | Kerry Whorton Cooper
Director
|
Sell | 1.3K | $20.6K |
| May 21, 2026 | Rajat Bahri
Director
|
Grant | 10.9K | - |
| May 21, 2026 | Cheryl Fae Campbell
Director
|
Grant | 10.9K | - |
| May 21, 2026 | Edward G. Cannizzaro
Director
|
Grant | 10.9K | - |
| May 21, 2026 | Kerry Whorton Cooper
Director
|
Grant | 17.6K | - |
| May 21, 2026 | Leo Paul Denault
Director
|
Grant | 10.9K | - |
| May 21, 2026 | Jessica L Denecour
Director
|
Grant | 10.9K | - |
| May 21, 2026 | Mark E. Ferguson III
Director
|
Grant | 10.9K | - |
| May 21, 2026 | William Craig Fugate
Director
|
Grant | 10.9K | - |
| May 21, 2026 | Arno Lockheart Harris
Director
|
Grant | 10.9K | - |
| May 21, 2026 | Carlos M. Hernandez
Director
|
Grant | 10.9K | - |
| May 21, 2026 | John O Larsen
Director
|
Grant | 10.9K | - |
| May 21, 2026 | William Lloyd Smith
Director
|
Grant | 10.9K | - |
| May 21, 2026 | Benjamin Francis Wilson
Director
|
Grant | 10.9K | - |
| Apr 28, 2026 | Jason M. Glickman
Officer
|
Sell | 47.3K | $772.8K |
| Apr 28, 2026 | Patricia K. Poppe
Chief Executive Officer
|
Sell | 31.3K | $512.2K |
| Mar 17, 2026 | Kerry Whorton Cooper
Director
|
Sell | 2.5K | $46.7K |
| Mar 16, 2026 | Carla J Peterman
Officer
|
Sell | 31.8K | $582.0K |
| Mar 16, 2026 | Carolyn Jeanne Burke
Chief Financial Officer
|
Grant | 144.8K | - |
| Mar 5, 2026 | Sumeet Singh
Officer
|
Sell | 55.7K | $1.0M |
| Mar 4, 2026 | Patricia K. Poppe
Chief Executive Officer
|
Grant | 236.5K | - |
| Mar 3, 2026 | Patricia K. Poppe
Chief Executive Officer
|
Grant | 32.3K | - |
| Mar 2, 2026 | Carolyn Jeanne Burke
Chief Financial Officer
|
Grant | 40.8K | - |
| Mar 2, 2026 | Jason M. Glickman
Officer
|
Grant | 27.5K | - |
| Mar 2, 2026 | Carla J Peterman
President
|
Grant | 31.4K | - |
| Mar 2, 2026 | Marlene Santos
Divisional Officer
|
Grant | 40.8K | - |
| Mar 2, 2026 | John R Simon
General Counsel
|
Grant | 36.5K | - |
| Mar 2, 2026 | John R Simon
General Counsel
|
Grant | 5.2K | - |
| Mar 2, 2026 | Sumeet Singh
Chief Executive Officer
|
Grant | 40.8K | - |
| Mar 2, 2026 | Alejandro T Vallejo
Officer
|
Grant | 11.8K | - |
| Mar 2, 2026 | Ajay Waghray
Chief Technology Officer
|
Grant | 15.7K | - |
| Mar 2, 2026 | Stephanie N. Williams
Officer
|
Grant | 7.4K | - |
| Feb 27, 2026 | Jason M. Glickman
Officer
|
Grant | 145.7K | - |
| Feb 27, 2026 | Carla J Peterman
Officer
|
Grant | 124.9K | - |
| Feb 27, 2026 | Patricia K. Poppe
Chief Executive Officer
|
Grant | 408.2K | - |
| Feb 27, 2026 | Patricia K. Poppe
Chief Executive Officer
|
Grant | 895.3K | - |
| Feb 27, 2026 | Marlene Santos
Divisional Officer
|
Grant | 216.5K | - |
| Feb 27, 2026 | John R Simon
General Counsel
|
Grant | 89.1K | - |
| Feb 27, 2026 | John R Simon
General Counsel
|
Grant | 145.7K | - |
| Feb 27, 2026 | Alejandro T Vallejo
Officer
|
Grant | 15.0K | - |
| Feb 27, 2026 | Stephanie N. Williams
Officer
|
Grant | 37.5K | - |
| Feb 19, 2026 | John R Simon
General Counsel
|
Sell | 50.0K | $900.0K |
| Feb 18, 2026 | Patricia K. Poppe
Chief Executive Officer
|
Sell | 31.3K | $559.4K |
| Nov 4, 2025 | John O Larsen
Director
|
Buy | 7.5K | $119.7K |
| Oct 30, 2025 | Jason M. Glickman
Divisional Officer
|
Sell | 29.5K | $470.1K |
| Oct 28, 2025 | Alejandro T Vallejo
Officer
|
Grant | 5.6K | - |
| Aug 11, 2025 | Mark E. Ferguson III
Director
|
Sell | 7.0K | $106.1K |
| May 22, 2025 | Rajat Bahri
Director
|
Grant | 10.6K | - |
| May 22, 2025 | Cheryl Fae Campbell
Director
|
Grant | 10.6K | - |
| May 22, 2025 | Edward G. Cannizzaro
Director
|
Grant | 10.6K | - |
| May 22, 2025 | Kerry Whorton Cooper
Director
|
Grant | 17.0K | - |
| May 22, 2025 | Leo Paul Denault
Director
|
Grant | 10.6K | - |
| May 22, 2025 | Jessica L Denecour
Director
|
Grant | 10.6K | - |
| May 22, 2025 | Mark E. Ferguson III
Director
|
Grant | 10.6K | - |
| May 22, 2025 | William Craig Fugate
Director
|
Grant | 10.6K | - |
| May 22, 2025 | Arno Lockheart Harris
Director
|
Grant | 10.6K | - |
| May 22, 2025 | Carlos M. Hernandez
Director
|
Grant | 10.6K | - |
| May 22, 2025 | John O Larsen
Director
|
Grant | 10.6K | - |
| May 22, 2025 | William Lloyd Smith
Director
|
Grant | 10.6K | - |
| May 22, 2025 | Benjamin Francis Wilson
Director
|
Grant | 10.6K | - |
| Apr 29, 2025 | Carla J Peterman
Officer
|
Sell | 32.5K | $562.6K |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.